Core Scientific (CORZ) Notes Payables (2021 - 2025)

Core Scientific (CORZ) has 5 years of Notes Payables data on file, last reported at $16.2 million in Q1 2025.

• Quarterly Notes Payables fell 30.51% year-over-year to $16.2 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $16.2 million (down 30.51% YoY) and the FY2024 annual result came in at $16.3 million, down 86.9% from the prior year.
• Notes Payables held at $16.2 million in Q1 2025 per CORZ's latest filing, from $16.3 million in the prior quarter.
• The five-year high for Notes Payables was $977.6 million in Q3 2022, with the low at $16.2 million in Q1 2025.
• Average Notes Payables over 5 years is $130.4 million, with a median of $35.9 million recorded in 2022.
• The widest YoY moves for Notes Payables: up 243.13% in 2023, down 87.28% in 2023.
• Core Scientific's Notes Payables stood at $76.0 million in 2021, then tumbled by 52.31% to $36.2 million in 2022, then soared by 243.13% to $124.4 million in 2023, then sank by 86.9% to $16.3 million in 2024, then declined by 0.47% to $16.2 million in 2025.
• Business Quant data shows CORZ's Notes Payables at $16.2 million in Q1 2025, $16.3 million in Q4 2024, and $17.9 million in Q3 2024.